Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05236465 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A 3-day Course for CFS/ME

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jan 1, 2026 to Jan 1, 2027
    • Study completion date: Dec 1, 2026 to Dec 1, 2028
    v5
  2. Primary completion date: Apr 1, 2024 to Jan 1, 2026
    • Study completion date: Apr 1, 2026 to Dec 1, 2026
    • Collaborators: 5 to 4
    v4
  3. Re-verified, no change to tracked fieldsv3
  4. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary completion date: Mar 1, 2024 to Apr 1, 2024
    • Study completion date: Mar 1, 2026 to Apr 1, 2026
    • Start date changed from estimate of Feb 15, 2022 to Mar 21, 2022
    • Site details revised
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Chronic fatigue syndrome/Myalgic encephalomyelitis (CFS/ME) can be a serious and disabling condition with a heavy symptom burden and low function. Work disability is common, and social life dramatically affected. CFS/ME is a challenging health problem as well as a societal problem. In recent years, a doubling of the number of patients with a CFS/ME diagnoses has been reported in Norway. The patient group represents a challenge for the health care system, the municipality, and the Norwegian Labour and Welfare Organization (NAV). According to new figures, the NAV pays 100 million Norwegian Kroner (NOK) each month in permanently incapacitated expenses for people with CFS/ME. Municipalities have expenses in form of care, rehabilitation and other measures. There is a lack of effective treatment for CFS/ME. Evidence-based knowledge is highly needed. If the 3-day course shows promising effects, this could have positive consequences for patients, relatives and health personnel, but also financially for the society and the municipality.
Trial Details
NCT Number NCT05236465
Lead Sponsor Norwegian University of Science and Technology
Collaborators: University of Oslo, Haukeland University Hospital, Lørenskog municipality, The Research Council of Norway
Conditions
(from sponsor)		 Chronic Fatigue Syndrome, Myalgic Encephalomyelitis
Related terms Fatigue, Fatigue Syndrome, Chronic, Health Education
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov